Personalized Medicines and Drugs

Personalized medicine (pm) has the potential to tailor therapy with the best response and highest safety margin to ensure better patient care. Sequencing of the human genome at the turn of the 21st century set in motion the transformation of personalized medicine from an idea to a practice. Pharmacogenomics” (pgx) – the study of variations of DNA and RNA characteristics as related to drug response – is a critically important area of personalized medicine where significant progress has recently been made. Personalized medicine’s greatest strides have been in cancer.  a targeted treatment targets a cancer’s specific genes and proteins that allow the cancer cells to grow and survive FDA determines that products are safe and effective before marketing through a careful evaluation of benefits and risks that considers the available scientific data in the context of the underlying condition or disease.
 

  • Protection and piracy
  • Personalised medicines:A decade of advancements
  • Cancer genomics
  • Pharmacogenomics
  • Good for patients but bad for drug companies

Related Conference of Personalized Medicines and Drugs

Personalized Medicines and Drugs Conference Speakers